NCT00992238View on ClinicalTrials.gov

A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

Not specified

Conditions
Healthy
Interventions
DRUG

Flavoxate Hydrochloride Tablets, 100mg

DRUG

Urispas® Tablets, 100mg

Trial Locations (1)

58104

PRACS Institute, Ltd, Fargo

Sponsors

Lead Sponsor

Padagis LLC
All Listed Sponsors
lead

Padagis LLC

INDUSTRY